References
- Herouy Y, Mellios P, Bandemir E, Dichmann S, Nockowski P, Schoph E, 2001; Inflammation in stasis dermatitis upregulates MMP-1, MMP-2 and MMP-13 expression. J Dermatol Sci. 25:198–205.
- Nicolaides AN. 2005; Chronic venous disease and the leukocyte-endothelium interaction: From symptom to ulceration. Angiology. 56:11–9.
- Pascarella L, Penn A, Schmid-schonbein GW. 2005; Venous hypertension and the inflammatory cascade: Major manifestations and trigger mechanism. Angiology. 56:3–10.
- Durand P, Prost M, Loreau N, Lussier-cacan S, Blache D. 2001; Impaired homocysteine metabolism and atherothrombotic disease. Lab Invest. 81:645–72.
- Dudman NP, Temple SE, Guo XW, Fu W, Perry MA. 1999; Homocysteine enhances neutrophil–endothelial interactions in both cultured human cells and rats in vivo. Circ Res. 84:409–16.
- Harker LA, Slichter SJ, Scott CR, Ross R. 1974; Homocystinemia. Vascular injury and arterial thrombosis. N Engl J Med. 291:537–43.
- Harker LA, Harlan JM, Ross R. 1983; Effect of sulfinpyrozone on homocysteine-induced endothelial injury and arteriosclerosis in baboons. Circ Res. 53:731–9.
- Den Heijer M, Rosentdaal FR, Bloom HJ, Gerrits WB, Bos GM. 1998; Hyperhomocysteinemia and venous thrombosis: A meta-analysis. Thromb Haemost. 80:874–7.
- Ray JG. 1998; Meta-analysis of hyperhomocysteinemia and risk factor for venous thromboembolic disease. Arch Intern Med. 158:2101–6.
- Wald DS, Law M, Morris JK. 2002; Homocysteine and cardiovascular disease: Evidence on causality from a meta-analysis. BMJ. 325:1202.
- Homocysteine STUDIES. 2002; Homocysteine and risk of ischemic heart disease and stroke: A meta-anlysis. JAMA 288:2015–22.
- Er H, Evereklioglu C, Cumurcu T, Turkoz Y, Ozerol E, Sahin K, 2002; Serum homocysteine level is increased and correlated with endothelin-1 and nitric oxide in Behcet's disease. Br J Ophthalmol. 86:653–7.
- Koga T, Claycombe K, Meydani M. 2002; Homocysteine increases monocyte and T-cell adhesion to human aortic endothelial cells. Atherosclerosis. 161:365–74.
- Li M, Chen J, Li YS, Feng YB, Gu X, Shi CZ. 2006; Folic acid reduces adhesion molecules VCAM-1 expression in aortic of rats with hyperhomocysteinemia. Int J Cardiol. 13:285–8.
- Silverman MD, Tumuluri RJ, Davis M, Lopez G, Rosenbaum JT, Lelkes PI. 2002; Homocysteine upregulates vascular cell adhesion molecule-1 expression in cultured human aortic endothelial cells and enhances monocyte adhesion. Arterioscler Thromb Vasc Biol. 22:587–92.
- Hofmann MA, Lalla E, Lu Y, Gleason MR, Wolf BM, Tanji N, 2001; Hyperhomocysteinemia enhances vascular inflammation and accelerates monocyte adhesion. J Clin Invest Dermatol. 107:675–83.
- Ozdemir R, Barutcu I, Sezgin AT, Acikgoz N, Ermis N, Esen AM, 2004; Vascular endothelial function and serum homocysteine levels in Behcet's disease. Am J Cardiol. 94:522–5.
- Selhub J, Jacques PF, Wilson PW, Rush D, Rosenberg IH. 1993; Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA. 270:2693–8.
- Naureth HJ, Joosten E, Riezler R, Stabler SP, Allen RH, Lindenbaum J. 1995; Effects of vitamin B12, folate, and vitamin B6 supplements in elderly people with normal serum vitamin concentrations. Lancet. 346:85–9.